Doxorubicin Hydrochloride|Epirubicin Hydrochloride|Rapamycin|5-Fluorouracil|Everolimus|Cabazitaxel|Valrubicin|Erlotinib Hydrochloride|Entecavir Monohydrate|Tenofovir Disoproxil Fumarate|Beijing Zhongshuo Pharmaceutical Technology Development Co. Ltd.

CPhI China 2020 (Booth No. ： W3B32-3)

Email Address
sales@chinazhongshuo.com

Phone
0086-10-64430626
0086-13801208576

Location : Home > Company Events

CPhI China 2020 (Booth No. ： W3B32-3)

Beijing ZhongShuo Pharmaceutical Technology Devel...

10

2020-11

More
Jiangxi QINGFENG Pharmaceutical Company, have processed site audit in our Hebei Production Base for two days.

5

2019-12

More
Zhejiang KINGLYUAN Pharmaceutical Company, have processed site audit in our Jiangsu Production Base for two days.

5

2019-12

More
Jilin XIUZHENG Pharmaceutical Company, have processed site audit in our Jiangsu Production Base for two days.

5

2019-12

More
Jiangsu CHIATAI QINGJIANG Pharmaceutical Company, have processed site audit in our Shandong Production Base for two days.

5

2019-12

More

About Us

Company Profile

Corporate Culture

Company License

Cooperation Partners

Products

Elderly frequently-occurring

Advantage Products

Contact Us

Sales Office:

R&D Office:

2nd, floor NPCPI, No. 16, 7th Area, Hepingli, Dongcheng District, Beijing, P.R.China

Liangshuihe Street, BDA, Beijing, P.R.China

0086-10-64430626

sales@chinazhongshuo.com

www.chinazhongshuo.com

WeChat

Copyright (C) 2019 Beijing Zhongshuo Pharmaceutical Technology Development Co. Ltd. All Rights Reserved.

+86-10-64430626
2286806018
Wechat
Top